Polymorphonuclear blood leukocytes and restenosis after intracoronary implantation of drug-eluting stents

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 2, 2009, Pages 130-136

  Gabbasov, Zufar A ^a   Kozlov, Sergey G ^a   Lyakishev, Anatoly A ^a   Saburova, Olga S ^a   Smirnov, Vladimir A ^a   Smirnov, Vladimir N ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Drug eluting stents; Eosinophils; Progenitor cells; Restenosis

Indexed keywords

OSTEONECTIN; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; BASOPHIL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESTENOSIS;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; OSTEONECTIN; PLATELET AGGREGATION INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 65249091954     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-107     Document Type: Conference Paper

References (32)

1. Caplice, N.M., Bunch, T.J., Stalboerger, P.G., Wang, S., Simper, D., Miller, D.V., et al. 2003. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc. Natl. Acad. Sci. U.S.A. 100(8): 4754-4759. doi:10.1073/pnas.0730743100. PMID:12665618.
2. Costa, M.A., and Simon, D.I. 2005. Molecular basis of restenosis and drug-eluting stents. Circulation, 111(17): 2257-2273. doi:10.1161/01.CIR.0000163587.36485.A7. PMID:15867193.
3. Friedenstein, A.J., Chailakhjan, R.K., and Lalykina, K.S. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3: 393-403. PMID:5523063.
4. Gabbasov, Z.A., Agapov, A.A., Saburova, O.S., Komlev, A.E., So- boleva, E.L., Akchurin, R.S., and Smirnov, V.N. 2007. Circulating stromal osteonectin-positive progenitor cells and stenotic coronary atherosclerosis. Can. J. Physiol. Pharmacol. 85(3-4): 295-300. doi:10.1139/Y07-001. PMID:17612637.
5. Grewe, P.H., Deneke, T., Machraoui, A., Barmeyer, J., and Müller, K.M. 2000. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J. Am. Coll. Cardiol. 35(1): 157-163. doi:10.1016/S0735-1097(99) 00486-6. PMID:10636274.
6. Honda, Y., Grube, E., de La Fuente, L.M., Yock, P.G., Stertzer, S.H., and Fitzgerald, P.J. 2001. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Circulation, 104(4): 380-383. doi:10.1161/hc2901.094149. PMID:11468196.
7. Horvath, C., Welt, F.G., Nedelman, M., Rao, P., and Rogers, C. 2002. Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ. Res. 90(4): 488-494. doi:10.1161/hh0402.105956. PMID:11884380.
8. Inoue, T., Sata, M., Hikichi, Y., Sohma, R., Fukuda, D., Uchida, T., et al. 2007. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on resteno- sis. Circulation, 115(5): 553-561. doi:10.1161/ CIRCULATIONAHA.106.621714. PMID:17261663.
9. Iwata, H., and Sata, M. 2007. Potential contribution of bone marrow-derived precursors to vascular repair and lesion formation: lessons from animal models of vascular diseases. Front. Biosci. 12: 4157-4167. doi:10.2741/2377. PMID:17485364.
10. Kastrati, A., Mehilli, J., von Beckerath, N., Dibra, A., Hausleiter, J., Pache, J., et al. 2005. Sirolimus-eluting stent or paclitaxel- eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA, 293(2): 165-171. doi:10.1001/ jama.293.2.165. PMID:15644543.
11. Kawano, H., Koide, Y., Baba, T., Nakamizo, R., Toda, G., Take- naka, M., and Yano, K. 2004. Granulation tissue with eosinophil infiltration in the restenotic lesion after coronary stent implantation. Circ. J. 68(7): 722-723. doi:10.1253/circj.68.722. PMID:15226642.
12. Komatsu, R., Ueda, M., Naruko, T., Kojima, A., and Becker, A.E. 1998. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation, 98(3): 224-233. PMID:9697822.
13. Lee, M.S., Pessegueiro, A., Zimmer, R., Jurewitz, D., and Tobis, J. 2008. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J. Invasive Cardiol. 20(8): 401-403. PMID:18688064.
14. Libby, P., Schwartz, D., Brogi, E., Tanaka, H., and Clinton, S.K. 1992. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation, 86(6 Suppl): III47-III52. PMID:1424051.
15. Mitra, A.K., and Agrawal, D.K. 2006. In stent restenosis: bane of the stent era. J. Clin. Pathol. 59(3): 232-239. doi:10.1136/jcp. 2005.025742. PMID:16505271.
16. Morice, M.C., Serruys, P.W., Sousa, J.E., Fajadet, J., Ban Hayashi, E., Perin, M., et al. 2002. A randomized comparison of a siroli- mus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 346: 1773-1780. doi:10.1056/ NEJMoa012843. PMID:12050336.
17. Nebeker, J.R., Virmani, R., Bennett, C.L., Hoffman, J.M., Samore, M.H., Alvarez, J., et al. 2006. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J. Am. Coll. Cardiol. 47(1): 175-181. doi:10. 1016/j.jacc.2005.07.071. PMID:16386683.
18. Rensing, B.J., Vos, J., Smits, P.C., Foley, D.P., van den Brand, M.J., van der Giessen, W.J., et al. 2001. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur. Heart J. 22: 2125-2130. doi:10.1053/euhj. 2001.2892. PMID:11686669.
19. Roberts, N., Jahangiri, M., and Xu, Q. 2005. Progenitor cells in vascular disease. J. Cell. Mol. Med. 9(3): 583-591. doi:10.1111/ j.1582-4934.2005.tb00490.x. PMID:16202207.
20. Sata, M. 2003. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc. Med. 13: 249-253. doi:10.1016/S1050-1738(03)00106-3. PMID:12922022.
21. Soboleva, E.L., and Popkova, V.M. 1989. Hemopoietic progenitor cells (CFU-GM) in the intima of human atheromatous aorta. Bull. Exp. Biol. Med. 5: 600-604.
22. Soboleva, E.L., Shindler, E.M., Saburova, O.S., Tvorogova, M.G., and Smirnov, V.N. 1994. In New pathogenic aspects of atherosclerosis. Nordrhein-Westfalische Academie der Wissenschaffen, Westdeutscher Verlag. pp. 79-93.
23. Soboleva, E.L., Gabbasov, Z.A., Agapov, A.A., Akchurin, R.S., Sa- burova, O.S., Romanov, Y.A., and Smirnov, V.N. 2005. Circulating bone marrow stem/progenitor cells in vascular atherogenesis and in non-invasive diagnosis of coronary stenosis. Exp. Clin. Cardiol. 10(3): 184-188.
24. Soda, T., Suzuki, H., Iso, Y., Kusuyama, T., Omori, Y., Sato, T., et al. 2007. Bone marrow cells contribute to neointimal formation after stent implantation in swine. Int. J. Cardiol. 121(1): 44-52. doi:10.1016/j.ijcard.2006.10.031. PMID:17254651.
25. Sousa, J.E., Costa, M.A., Abizaid, A., Abizaid, A.S., Feres, F., Pinto, I.M., et al. 2001. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation, 103(2): 192-195. PMID:11208675.
26. Sousa, J.E., Costa, M.A., Abizaid, A., Feres, F., Seixas, A.C., Ta- najura, L.F., et al. 2005. Four-year angiographic and intravascu- lar ultrasound follow-up of patients treated with sirolimus eluting stents. Circulation, 111: 2326-2329. doi:10.1161/01.CIR. 0000164271.01172.1A. PMID:15851603.
27. Tanaka, H., Skhova, G.K., Swanson, S.J., Clinton, S.K., Ganz, P., Cybulsky, M.I., and Libby, P. 1993. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation, 88(pt 1): 1788-1803. PMID: 7691431.
28. Thurau, A.M., Schylz, U., Wolf, V., Krug, N., and Schauer, U. 1996. Identification of eosinophils by flow cytometry. Cytome- try, 23(2): 150-158. doi:10.1002/(SICI)1097-0320(19960201) 23:2<150::AID-CYTO8>3.0. CO;2-O. PMID:8742174.
29. Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., et al. 2004. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation, 109(6): 701-705. doi:10.1161/01.CIR. 0000116202.41966.D4. PMID:14744976.
30. Weil, G.J., and Chused, T.M. 1981. Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood, 57(6): 1099-1104. PMID:7225570.
31. Welt, F.G., and Rogers, C. 2002. Inflammation and restenosis in the stent era. Arterioscler. Thromb. Vasc. Biol. 22(11): 1769-1776. doi:10.1161/01.ATV.0000037100.44766.5B. PMID: 12426203.
32. Welt, F.G., Edelman, E.R., Simon, D.I., and Rogers, C. 2000. Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler. Thromb. Vasc. Biol. 20(12): 2553-2558. PMID:11116052.